SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-017255
Filing Date
2024-04-30
Accepted
2024-04-30 16:40:40
Documents
16
Period of Report
2024-04-25
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45116
2 ex3-1.htm EX-3.1 9979
  Complete submission text file 0001493152-24-017255.txt   283129

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bfri-20240425.xsd EX-101.SCH 3967
4 XBRL DEFINITION FILE bfri-20240425_def.xml EX-101.DEF 26984
5 XBRL LABEL FILE bfri-20240425_lab.xml EX-101.LAB 37210
6 XBRL PRESENTATION FILE bfri-20240425_pre.xml EX-101.PRE 25604
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6761
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 24897996
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)